Publications

  1. Gerkin RC, Adler CH, Hentz JG, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Caviness JN, Dugger BN, Serrano G, Belden C, Smith BH, Sue L, Davis KJ, Zamrini E, Beach TG. Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype. Ann Clin Transl Neurol. 2017 Oct; 4 (10):714-721 Epub 2017 Sept 08
    View PubMed
  2. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings. Mov Disord. 2017 May; 32: (5)722-723.
    View PubMed
  3. Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG, Arizona Study of Aging Neurodegenerative Disorders. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Mov Disord. 2017 Feb; 32: (2)274-277.
    View PubMed
  4. de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ. A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement. J Parkinsons Dis. 2017; 7 (3):533-543
    View PubMed
  5. Gupta HV, Lyons MK, Mehta SH. Teaching NeuroImages: Noninfectious cyst as an unusual complication of deep brain stimulation. Neurology. 2016 Nov 1; 87: (18)e223-e224.
    View PubMed
  6. Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG. Graph theory network function in Parkinson's disease assessed with electroencephalography. Clin Neurophysiol. 2016 May; 127: (5)2228-36.
    View PubMed
  7. Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts. Eur J Neurol. 2016 Feb; 23: (2)387-92.
    View PubMed
  8. Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings. Mov Disord. 2016 Feb; 31: (2)250-6.
    View PubMed
  9. Mehta SH, Adler CH. Advances in Biomarker Research in Parkinson's Disease. Curr Neurol Neurosci Rep. 2016 Jan; 16: (1)7.
    View PubMed
  10. Gupta HV, Gervais C, Ross MA, Mehta SH. Purkinje Cell Cytoplasmic Antibody (PCA-2)-related Chorea-Dystonia Syndrome. Tremor Other Hyperkinet Mov (N Y). 2016; 6:420.
    View PubMed
  11. Silver MR, Sethi KD, Mehta SH, Nichols FT, Morgan JC. Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA). BMC Neurol. 2015 Dec 18; 15:260.
    View PubMed
  12. Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH. Simplified conversion method for unified Parkinson's disease rating scale motor examinations. Mov Disord. 2015 Dec; 30: (14)1967-70.
    View PubMed
  13. Mehta SH, Morgan JC, Sethi KD. Drug-induced movement disorders. Neurol Clin. 2015 Feb; 33(1):153-74.
    View PubMed
  14. Fowler RA, Mittmann N, Geerts WH, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D, Canadian Critical Care Trials Group//Australia and New Zealand Intensive Care Society Clinical Trials Group. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial. Trials. 2014 Dec 20; 15:502.
    View PubMed
  15. Mehta SH, Switzer JA, Biddinger P, Rojiani AM. IgG4-related leptomeningitis: a reversible cause of rapidly progressive cognitive decline. Neurology. 2014 Feb 11; 82(6):540-2.
  16. Wakade CG, Mehta SH, Maeda M, et al. Axonal fasciculation and the role of polysialic acid-neural cell adhesion molecule in rat cortical neurons. J Neurosci Res. 2013 Nov; 91(11):1408-18. Epub 2013 Aug
  17. Herz NB, Mehta SH, Sethi KD, Jackson P, Hall P, Morgan JC. Nintendo Wii rehabilitation ("Wii-hab") provides benefits in Parkinson's disease. Parkinsonism Relat Disord. 2013 Nov; 19(11):1039-42. Epub 2013 Aug
  18. Mehta SH, Nichols FT 3rd, Espay AJ, Duker AP, Morgan JC, Sethi KD. Dilated Virchow-Robin spaces and parkinsonism. Mov Disord. 2013 May; 28(5):589-90. Epub 2013 Apr 10.
    View PubMed
  19. Giller C, Mehta S, Yanasak N, Jenkins P. Avoidance of electrode related MRI artifact during staged deep brain stimulator implantation. J Neurol Surg A Cent Eur Neurosurg. 2012 Sep; 73(5):320-3. Epub 2012 Jul 30.
    View PubMed
  20. Sethi KD, Mehta SH. A clinical primer on restless legs syndrome: what we know, and what we don't know. Am J Manag Care. 2012 Aug; 18(5 Suppl):S83-8.
    View PubMed
  21. Chong RK, Lee KH, Morgan J, Mehta SH, Hall P, Sethi K. Diagnostic value of the rapid assessment of postural instability in Parkinson's disease (RAPID) questionnaire. Int J Clin Pract. 2012 Jul; 66(7):718-21.
    View PubMed
  22. Chong RK, Morgan J, Mehta SH, Pawlikowska I, Hall P, Ellis AV, Ibanez-Wong AD, Miller GM, Baugh K, Sethi K. Rapid assessment of postural instability in Parkinson's disease (RAPID): a pilot study. Eur J Neurol. 2011 Feb; 18(2):260-5.
    View PubMed
  23. Morgan JC, Mehta SH, Sethi KD. Biomarkers in Parkinson's disease. Curr Neurol Neurosci Rep. 2010 Nov; 10(6):423-30.
    View PubMed
  24. Mehta SH, Morgan JC, Sethi KD. Paraneoplastic movement disorders. Curr Neurol Neurosci Rep. 2009 Jul; 9(4):285-91.
    View PubMed
  25. Mehta SH, Prakash R, Prisant LM, Isales CM, Morgan JC, Williams H, Sethi KD. Diagnosis of pheochromocytoma in the setting of Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):343-7.
    View PubMed
  26. Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol. 2009 May; 11(3):170-8.
    View PubMed
  27. Mehta SH, Morgan JC, Sethi KD. Neuroimaging and transcranial ultrasonography in Parkinson's disease. Curr Neurol Neurosci Rep. 2008 Jul; 8(4):297-303.
    View PubMed
  28. Mehta SH, Morgan JC, Sethi KD. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment. CNS Spectr. 2008 Mar; 13(3 Suppl 4):6-11.
    View PubMed
  29. Marrufo M, Politsky J, Mehta S, Morgan JC, Sethi KD. Paroxysmal Kinesigenic Segmental Myoclonus due to a spinal cord glioma. Mov Disord. 2007 Sep 15; 22(12):1801-3.
    View PubMed
  30. Mehta SH, Adams RJ. Treatment and prevention of stroke in children with sickle cell disease. Curr Treat Options Neurol. 2006 Nov; 8(6):503-12.
    View PubMed
  31. Slovut DP, Mehta SH, Dorrance AM, Brosius FC, Watts SW, Webb RC. Increased vascular sensitivity and connexin43 expression after sympathetic denervation. Cardiovasc Res. 2004 May 1; 62(2):388-96.
    View PubMed
  32. Mehta SH, Webb RC, Ergul A, Tawfik A, Dorrance AM. Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Integr Comp Physiol. 2004 Feb; 286(2):R283-8. Epub 2003 Oct 30.
    View PubMed
  33. Mehta SH, Dhandapani KM, De Sevilla LM, Webb RC, Mahesh VB, Brann DW. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology. 2003 Jan; 77(1):44-50.
    View PubMed
  34. Komalavilas P, Mehta S, Wingard CJ, Dransfield DT, Bhalla J, Woodrum JE, Molinaro JR, Brophy CM. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol (1985). 2001 Oct; 91(4):1819-27.
    View PubMed